Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021.
Stepanishyna Y, Manni M, Civallero M, Shokun N, Skrypets T, Burtna A, Shapovalenko N, Tytorenko I, Aleksyk O, Pastushenko Y, Gubareva H, Moiseienko K, Kadnikova T, Rudyuk T, Filonenko K, Martynchyk A, Novosad O, Galli GR, Kryachok I, Federico M. Stepanishyna Y, et al. Among authors: tytorenko i. Br J Haematol. 2024 May;204(5):1757-1761. doi: 10.1111/bjh.19352. Epub 2024 Feb 23. Br J Haematol. 2024. PMID: 38400556
NOT OTHERWISE SPECIFIED T-CELL LYMPHOMA: OUTCOMES OF A SINGLE CENTER STUDY.
Kriachok I, Tytorenko I, Shudrak N, Aleksik O, Stepanishyna Y, Kadnikova T, Pastushenko Y, Shokun N, Rudiyk T, Bushuieva M. Kriachok I, et al. Among authors: tytorenko i. Exp Oncol. 2024 Feb 3;45(4):474-482. doi: 10.15407/exp-oncology.2023.04.474. Exp Oncol. 2024. PMID: 38328842
THE ROLE OF RADIATION THERAPY IN THE TREATMENT OF PTCL-NOS.
Kriachok I, Aleksyk O, Tytorenko I, Bushuieva M, Moroz Y. Kriachok I, et al. Among authors: tytorenko i. Probl Radiac Med Radiobiol. 2023 Dec;28:504-512. doi: 10.33145/2304-8336-2023-28-504-512. Probl Radiac Med Radiobiol. 2023. PMID: 38155144 English, Ukrainian.
Ukrainian prospective study in patients with T-cell non-Hodgkin lymphomas.
Kriachok I, Shudrak N, Tytorenko I, Stepanishyna Y, Martynchik A, Aleksik O, Novosad O, Kadnikova T, Pastushenko Y, Kyschevoy E, Shokun N. Kriachok I, et al. Among authors: tytorenko i. Exp Oncol. 2021 Dec;43(4):346-350. doi: 10.32471/exp-oncology.2312-8852.vol-43-no-4.17151. Exp Oncol. 2021. PMID: 34967534
[Efficiency therapy with rituximab in patients with non-Hodgkin's lymphomas].
Kriachok IA, Filonenko KS, Gubareva GO, Tytorenko IB, Novosad OI, Kadnikova TV, Aleksik OM, Martynchyk AV, Kushchevyĭ ÉV, Pastushenko IaV, Kutsenko LB. Kriachok IA, et al. Among authors: tytorenko ib. Lik Sprava. 2011 Jan-Mar;(1-2):117-21. Lik Sprava. 2011. PMID: 21954645 Ukrainian.
[The treatment of patients with refractory forms of Hodgkin's lymphomas].
Hubareva HO, Kriachok IA, Tytorenko IB, Aleksyk OM, Novosad OI, Kadnikova TV, Martynchyk AV, Pastushenko IaV, Filonenko KS, Kushchevyĭ IeV. Hubareva HO, et al. Among authors: tytorenko ib. Lik Sprava. 2010 Jan-Mar;(1-2):115-8. Lik Sprava. 2010. PMID: 20608037 Clinical Trial. Ukrainian.